These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 1370774

  • 21. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 22. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ.
    J Exp Med; 1990 Jan 01; 171(1):345-9. PubMed ID: 1688611
    [Abstract] [Full Text] [Related]

  • 23. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
    Livingston PG, Kurane I, Ennis FA.
    J Virol Methods; 1997 Aug 01; 67(1):77-84. PubMed ID: 9274820
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB.
    J Virol; 1993 Dec 01; 67(12):7428-35. PubMed ID: 7693972
    [Abstract] [Full Text] [Related]

  • 26. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
    Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W.
    J Virol; 1995 Aug 01; 69(8):4872-9. PubMed ID: 7609055
    [Abstract] [Full Text] [Related]

  • 27. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 01; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 28. The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genes.
    Reitnauer PJ, DeMars R, Sondel PM.
    Hum Immunol; 1985 Jul 01; 13(3):177-91. PubMed ID: 2989227
    [Abstract] [Full Text] [Related]

  • 29. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL, Pye SJ, Schmidt C, Cross SM, Silins SL, Misko IS.
    J Infect Dis; 1997 Oct 01; 176(4):1068-72. PubMed ID: 9333169
    [Abstract] [Full Text] [Related]

  • 30. Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL.
    Avila-Cariño J, Végh Z, Klein E.
    Mol Immunol; 1994 Jan 01; 31(1):59-63. PubMed ID: 8302299
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
    Ebihara T, Sakai N, Koyama S.
    Tohoku J Exp Med; 1990 Nov 01; 162(3):213-24. PubMed ID: 1965352
    [Abstract] [Full Text] [Related]

  • 33. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP.
    J Exp Med; 1995 Dec 01; 182(6):1703-15. PubMed ID: 7500015
    [Abstract] [Full Text] [Related]

  • 34. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A, Fu Z, Underwood LJ, Bondurant KL, Rochford R, Cannon MJ.
    J Immunol; 2003 Mar 15; 170(6):3187-94. PubMed ID: 12626577
    [Abstract] [Full Text] [Related]

  • 35. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Argaet VP, Misko IS.
    J Exp Med; 1996 Nov 01; 184(5):1815-24. PubMed ID: 8920869
    [Abstract] [Full Text] [Related]

  • 36. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 37. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 15; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 38. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.
    Long HM, Haigh TA, Gudgeon NH, Leen AM, Tsang CW, Brooks J, Landais E, Houssaint E, Lee SP, Rickinson AB, Taylor GS.
    J Virol; 2005 Apr 15; 79(8):4896-907. PubMed ID: 15795275
    [Abstract] [Full Text] [Related]

  • 39. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB.
    J Virol; 2003 Nov 15; 77(21):11507-16. PubMed ID: 14557636
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
    D'Orsogna LJ, van den Heuvel H, van der Meer-Prins EM, Roelen DL, Doxiadis II, Claas FH.
    J Immunol; 2012 Nov 15; 189(10):4825-31. PubMed ID: 23077240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.